StemTech International Official Website

23 May 2008 The Edge Daily

StemTech automates stem cell processing

KUALA LUMPUR: StemTech International Sdn Bhd, a subsidiary of TMC Life Sciences Bhd, has recently invested in the FACSCalibur Cytometer instrument from the US that is capable of CD34 cell analysis and cell viability test to meet the productivity requirements of its clinical laboratory.

In a statement yesterday, the company said the handing over and commissioning of the equipment took place at its Kota Damansara laboratory, witnessed by its executive director Wenddi-Anne Chong.

StemTech’s primary activity is cord blood and adult stem cell harvesting, processing and cryo-preservation.

Chong said the company was the first in the region to implement an automated processing technology system, named AXP AutoXpress that gives higher stem cell yield, translating into a higher successful survival rate in transplantation.

Styled for a good cause
A glossy coffeetable book called Portraits of Hope 3, featuring 52 glamorous Malaysians, hopes to raise funds for The Queen’s Foundation through its sales.

More Detail

SEGi and Tropicana Medical Centre Signs Memorandum Of Understanding
SEGi College, Malaysia and Tropicana Medical Centre signed a Memorandum of Understanding (MOU) today witnessed by the Y. Bhg. Dato’ Seri Dr. Hj. Mohd. Nasir bin. Mohd Ashraf, Secretary General of the Ministry of Health, representing the Minister of Health, YB Dato’ Liow Tiong Lai.

More Detail

StemTech automates stem cell processing
StemTech International Sdn Bhd, a subsidiary of TMC Life Sciences Bhd, has recently invested in the FACSCalibur Cytometer instrument from the US that is capable of CD34 cell analysis and cell viability test to meet the productivity requirements of its clinical laboratory.

More Detail

There’s life in stem cell banking
THE umbilical cords of babies born in the era of our mothers or grandmothers were usually treated as an insignificant part of the babies and were either thrown away or kept for cultural or traditional purposes.

More Detail

TMC Life to expand ops in Indonesia
TMC Life Sciences Bhd, a fertility treatment provider, plans to set up a fertility treatment centre and a second laboratory in Indonesia as it expands operations in Southeast Asia.

More Detail

TMC Life Sciences Bhd subsidiary StemTech International Sdn Bhd is looking at expanding regionally, according to chief executive officer Michael Chua.

More Detail

TMC Life set to expand regionally
TMC Life Sciences Bhd subsidiary StemTech International Sdn Bhd is looking at expanding regionally, according to chief executive officer Michael Chua.

More Detail

Bulletin Issue: 2008-505
We cordially thanked Datuk Dr. Hj. Abd. Latiff b. Ahmad, Deputy Minister of Health, Malaysia for officiating the grand opening ceremony of StemTech International.

More Detail

Bulletin Issue: 2008-504

More Detail

Bulletin Issue: 2008-503
We are proud to announce that the Ministry of Health has awarded StemTech International Sdn Bhd the license to operate a Private Blood Bank in Malaysia, which covers Stem Cell Banking.

More Detail

Bulletin Issue: 2008-501

More Detail

StemTech International brings the latest News in Stem Cell Research:
Cord Blood Stem Cells And Cardiovascular Disease

More Detail

Coming soon...

	1st to deploy the Automated Processing Technology in Malaysia. More Detail

	Why presserve your Baby’s Stem Cell? More Detail

	Committed to bringing Hope into Reality. More Detail

	Contact us now for more! +6 016-205 7000 +6 03-6141 8881

	Email Subscription Service Receive exclusive offers & valuable news updates. More Detail

	TMC Life Sciences Bhd Visit Website